AP NEWS

Global Breast Cancer Epidemiology and Patient Flow Analysis - 2018 - ResearchAndMarkets.com

June 11, 2018

DUBLIN--(BUSINESS WIRE)--Jun 11, 2018--The “Global Breast Cancer Epidemiology and Patient Flow Analysis - 2018” report has been added to ResearchAndMarkets.com’s offering.

The research provides insights into Breast Cancer epidemiology, Breast Cancer diagnosed patients, and Breast Cancer treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Breast Cancer derived from epidemiological analysis, patients diagnosed with Breast Cancer, and patients treated with a drug therapy.

The research study helps executives estimate Breast Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Breast Cancer prevalence, Breast Cancer diagnosis rate, and Breast Cancer treatment rate for the period 2017-2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Features of the Report

Breast Cancer Patient Flow Breast Cancer Prevalence Breast Cancer Diagnosed Patients Breast Cancer Treated Patients

Key Topics Covered

1. Breast Cancer: Disease Definition

2. Global Breast Cancer Patient Flow

2A. Global Breast Cancer Prevalence

2B. Global Breast Cancer Diagnosed Patients

2C. Global Breast Cancer Treated Patients

3. Breast Cancer Patient Flow in the US

3A. Breast Cancer Prevalence in the US

3B. Breast Cancer Diagnosed Patients in the US

3C. Breast Cancer Treated Patients in the US

4. Breast Cancer Patient Flow in Europe

4A. Breast Cancer Prevalence in Europe

4B. Breast Cancer Diagnosed Patients in Europe

4C. Breast Cancer Treated Patients in Europe

5. Breast Cancer Patient Flow in Germany

5A. Breast Cancer Prevalence in Germany

5B. Breast Cancer Diagnosed Patients in Germany

5C. Breast Cancer Treated Patients in Germany

6. Breast Cancer Patient Flow in France

6A. Breast Cancer Prevalence in France

6B. Breast Cancer Diagnosed Patients in France

6C. Breast Cancer Treated Patients in France

7. Breast Cancer Patient Flow in Spain

7A. Breast Cancer Prevalence in Spain

7B. Breast Cancer Diagnosed Patients in Spain

7C. Breast Cancer Treated Patients in Spain

8. Breast Cancer Patient Flow in Italy

8A. Breast Cancer Prevalence in Italy

8B. Breast Cancer Diagnosed Patients in Italy

8C. Breast Cancer Treated Patients in Italy

9. Breast Cancer Patient Flow in UK

9A. Breast Cancer Prevalence in UK

9B. Breast Cancer Diagnosed Patients in UK

9C. Breast Cancer Treated Patients in UK

10. Breast Cancer Patient Flow in Japan

10A. Breast Cancer Prevalence in Japan

10B. Breast Cancer Diagnosed Patients in Japan

10C. Breast Cancer Treated Patients in Japan

11. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/fnxsqk/global_breast?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180611006199/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Breast Cancer Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/11/2018 04:44 PM/DISC: 06/11/2018 04:44 PM

http://www.businesswire.com/news/home/20180611006199/en

AP RADIO
Update hourly